Assessment and Management of Foot Disease in Patients with Diabetes

Abstract
The human and financial costs of lower-extremity amputation in patients with diabetes mellitus are well recognized1. However, the rates of major amputation in the United States remain high,2 in part because present knowledge regarding the prevention and management of foot disease is not widely applied in clinical practice. The U.S. Department of Health has set a goal for the year 2000 of a 40 percent reduction in amputation rates among diabetic patients3. Methods to achieve this goal are available today. For example, in the majority of diabetic patients, the initial condition that eventually leads to amputation is a . . .